These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10271653)

  • 21. P & T Committee interview: Promoting rational drug use.
    Hunt TK; Herfindal ET
    Hosp Formul; 1988 Apr; 23(4):359-62, 365-6, 369. PubMed ID: 10286839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What should your formulary look like?
    Lanser EG
    Healthc Exec; 2002; 17(1):52. PubMed ID: 11822245
    [No Abstract]   [Full Text] [Related]  

  • 23. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
    Segal R; Pathak DS
    Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of formulary development in a small hospital.
    Holt RT; Larson DS; Scheil ES
    Hosp Pharm; 1988 Jul; 23(7):649-52, 656, 666. PubMed ID: 10288268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing a quick reference formulary.
    Huntzinger PE
    Mil Med; 2001 Oct; 166(10):881-3. PubMed ID: 11603239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulary in a small hospital.
    Tuttle GA; Preston LW
    Hosp Pharm; 1978 Feb; 13(2):106, 110. PubMed ID: 10306345
    [No Abstract]   [Full Text] [Related]  

  • 27. Communicating P & T guidelines: how one committee meets the challenge.
    Dreyfus R; Bender F
    Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Creating an ostomy product formulary.
    Turnbull G
    Ostomy Wound Manage; 2002 Mar; 48(3):14-5. PubMed ID: 11968889
    [No Abstract]   [Full Text] [Related]  

  • 29. Ohio hospital formularies: an analysis of structure, process, and outcome.
    Parrish RH; Berger BA
    Hosp Pharm; 1985 Aug; 20(8):600-3, 606-11. PubMed ID: 10289647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of removing oral neuroleptic liquids from the formulary of a large psychiatric hospital.
    Jewett C; Sramek J; Itow G; Alcorn V
    Hosp Formul; 1988 Mar; 23(3):288-91, 295-6. PubMed ID: 10314656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How our request form helps us to admit drugs to the formulary.
    Konitzer LM; Turner J
    Pharm Times; 1985 Apr; 51(4):64-5, 67. PubMed ID: 10270851
    [No Abstract]   [Full Text] [Related]  

  • 33. A survey of drug formulary procedures in Naval Hospitals and the feasibility of change.
    Lucas JR; Winship HW
    Mil Med; 1976 Jan; 141(1):13-20. PubMed ID: 814484
    [No Abstract]   [Full Text] [Related]  

  • 34. Financial impact of formulary revision of second-generation cephalosporins.
    Andrews JD; Hafting S
    Can J Hosp Pharm; 1988 Jun; 41(3):125-7. PubMed ID: 10288499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modern ways of actualisation of military formulary system].
    Miroshnichenko IuV; Goriachev AB; Krasavin KD; Golubenko RA; Gaĭnov VS; Tikhonov VS; Stavila AG; Klochkova IV
    Voen Med Zh; 2014 Jun; 335(6):59-64. PubMed ID: 25286576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost savings through formulary implementation and group purchasing in four therapeutic categories.
    Sylvester KL; Wudds TW
    Hosp Formul; 1986 Mar; 21(3):357-60, 369-70. PubMed ID: 10275579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASHP technical assistance bulletin on hospital formularies.
    Am J Hosp Pharm; 1985 Feb; 42(2):375-7. PubMed ID: 3976687
    [No Abstract]   [Full Text] [Related]  

  • 38. Perspectives on the hospital formulary.
    Hoffmann RP
    Hosp Pharm; 1984 May; 19(5):359-61, 364. PubMed ID: 10266244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of patient satisfaction with a formulary switch from omeprazole to lansoprazole in gastroesophageal reflux disease maintenance therapy.
    Condra LJ; Morreale AP; Stolley SN; Marcus D
    Am J Manag Care; 1999 May; 5(5):631-8. PubMed ID: 10537869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.